MedTrace Logo

OverTTuRe: Characteristics, Treatment Patterns and Outcomes of Patients With ATTR Amyloidosis

NCT06355934 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 52121

Last updated 2026-05-19

No results posted yet for this study

Summary

The overall aim of this observational study is to generate real-world evidence on the pre- and post-diagnosis disease journeys, including baseline characteristics, treatment patterns and selected clinical, economic, and humanistic outcomes (for example Health Related Quality of Life (HRQoL), Neuropathy impairment score, activities of daily living (ADL) assessments) in patients with ATTR amyloidosis, and to better understand how the disease is presented.

Conditions

  • ATTR Amyloidosis

Interventions

OTHER

no intervention

not applicable, this is an observational retrospective data analysis study; no interventions in the study

Sponsors & Collaborators

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-08-21
Primary Completion
2026-09-30
Completion
2026-09-30

Countries

  • United States
  • Canada
  • China
  • Denmark
  • Germany
  • Japan
  • Portugal
  • Spain
  • Sweden
  • United Kingdom

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06355934 on ClinicalTrials.gov